Skip to main content
. 2022 Jan 14;375(6577):eabi9069. doi: 10.1126/science.abi9069

Table 3. WHO-defined COVID-19 symptoms, expressed in prevalence ratios.

All regressions include an indicator for each control-intervention pair. The regressions “with baseline controls” include controls for baseline rates of proper mask-wearing and baseline symptom rates. “Baseline symptom rate” is defined as the rate of surveyed individuals in a village who report symptoms coinciding with the WHO definition of a probable COVID-19 case. We assume that (i) all reported symptoms were acute onset, (ii) all people live or work in an area with a high risk of transmission of virus, and (iii) all people have been a contact of a probable or confirmed case of COVID-19 or are linked to a COVID-19 cluster. The analysis includes all people surveyed in the baseline household visits, excluding individuals for whom we did not collect midline or endline symptoms. Blank spaces indicate variables not included in the regression specification reported in each column.

Parameter Intervention effect Intervention effect by mask type
No baseline controls
Intervention prevalence ratio 0.885***
[0.834, 0.934]
 Intervention prevalence ratio for surgical mask villages 0.865***
[0.803, 0.928]
 Intervention prevalence ratio for cloth mask villages 0.922*
[0.838, 1.005]
Average symptomatic rate in paired control villages 0.0860 0.0860
With baseline controls
Intervention prevalence ratio 0.884***
[0.834, 0.934]
 Intervention prevalence ratio for surgical mask villages 0.874***
[0.809, 0.939]
 Intervention prevalence ratio for cloth mask villages 0.907**
[0.823, 0.991]
N individuals 321,948 321,948
N villages 572 572

***Significant at the 1% level.

**Significant at the 5% level.

*Significant at the 10% level.

†We report the mean rate of symptomatic status at endline. This is not equivalent to the coefficient on the constant due to the inclusion of the pair indicators as controls.